CLINICAL_TRIALS
trial_result
· 2022-12-09
Clinical Trial Update: Fruquintinib Plus Irinotecan in the Treatment of Advanced Gastric Cancer [Phase 2]
Summary
Phase 2 clinical trial investigating fruquintinib plus irinotecan for advanced gastric cancer is in an unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fujian Medical University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN